Avalon’s 4th annual Lab Trend Report, the only one of its kind in the industry, examines emerging industry trends and legislation currently shaping the lab ecosystem for healthcare executives.

This year’s report includes:

• Market trends affecting laboratory diagnostics and health plans
• Details on the recent FDA LDT Final Rule and the legislative and regulatory landscape impacting genetic and routine testing
• An exploration of the growing reliance on genetic testing for disease prediction and its impact on the industry
• An exploration of the recent and significant increase in the utilization of biomarkers as a tool for predicting disease risk
• How Avalon programs can address waste, price concerns, and spend